Novo Nordisk spotlights star diabetes drugs in massive TV ad campaigns
In 2021, pharmaceutical firm Novo Nordisk spent enormous sums of money on advertising diabetes drugs Ozempic and Rybelsus. (Corrected)
.jpg)
by benjamin werner Christensen, translated by daniel pedersen
(Corrected at 9:25 am, January 25: An earlier version of the article did not contain sales figures in the correct currency for Rybelsus and Ozempic.)
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
.jpg)
Catalent behind Novo Nordisk's supply issues, says media
For subscribers
